Literature DB >> 7747298

Visceral leishmaniasis in Somalia: prevalence of leishmanin-positive and seropositive inhabitants in an endemic area.

S A Shiddo1, H O Akuffo, A A Mohamed, G Huldt, L A Nilsson, O Ouchterlony, R Thorstensson.   

Abstract

In an endemic area of Somalia both humoral and cell mediated immunity against Leishmania donovani was demonstrated in 246 inhabitants. In a study of 14 patients with active visceral leishmaniasis, we found that antibodies appear early in infection and that they are then demonstrable for a limited period only. Leishmanin positivity develops later and persists longer, but does not seem to be lifelong. The majority of the immunoreactive individuals were either sero- or leishmanin positive. This finding is in accord with the result obtained in recent experimental studies indicating a regulatory effect exerted on humoral and cell mediated immunity by different T lymphocyte subsets.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7747298     DOI: 10.1016/0035-9203(95)90640-1

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  9 in total

Review 1.  Laboratory diagnosis of visceral leishmaniasis.

Authors:  Shyam Sundar; M Rai
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

2.  Antileishmania immunological tests for asymptomatic subjects living in a visceral leishmaniasis-endemic area in Brazil.

Authors:  Luciana Almeida Silva; Héctor Dardo Romero; Gabriel Antônio Nogueira Nascentes; Roberto Teodoro Costa; Virmondes Rodrigues; Aluízio Prata
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

3.  Use of noninvasive markers to detect Leishmania infection in asymptomatic human immunodeficiency virus-infected patients.

Authors:  José A García-García; Joaquina Martín-Sánchez; Montserrat Gállego; Antonio Rivero-Román; Angela Camacho; Cristina Riera; Francisco Morillas-Márquez; Salvador Vergara; Juan Macías; Juan A Pineda
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

4.  Anti-leishmania infantum IgG antibody avidity in visceral leishmaniasis.

Authors:  Monique Gomes Salles Tiburcio; Laís Anversa; Kelly Aparecida Kanunfre; Antonio Walter Ferreira; Virmondes Rodrigues Júnior; Luciana de Almeida Silva
Journal:  Clin Vaccine Immunol       Date:  2013-09-04

Review 5.  Leishmaniasis Beyond East Africa.

Authors:  Caitlin M Jones; Susan C Welburn
Journal:  Front Vet Sci       Date:  2021-02-26

6.  Heterogeneity of Leishmania donovani parasites complicates diagnosis of visceral leishmaniasis: comparison of different serological tests in three endemic regions.

Authors:  Elfadil Abass; Cholho Kang; Franjo Martinkovic; Saul J Semião-Santos; Shyam Sundar; Peter Walden; Renaud Piarroux; Abdallah El Harith; Michael Lohoff; Ulrich Steinhoff
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

Review 7.  Visceral leishmaniasis in Somalia: A review of epidemiology and access to care.

Authors:  Temmy Sunyoto; Julien Potet; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2017-03-09

Review 8.  A review of the leishmanin skin test: A neglected test for a neglected disease.

Authors:  Jessica Carstens-Kass; Kayla Paulini; Patrick Lypaczewski; Greg Matlashewski
Journal:  PLoS Negl Trop Dis       Date:  2021-07-22

9.  rKLO8, a novel Leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in Sudan.

Authors:  Elfadil Abass; Nadine Bollig; Katharina Reinhard; Bärbel Camara; Durria Mansour; Alexander Visekruna; Michael Lohoff; Ulrich Steinhoff
Journal:  PLoS Negl Trop Dis       Date:  2013-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.